What does CoC standard 4.7 require regarding clinical trials?

• A. Patients must participate in trials regardless of choice
• B. Cancer programs must inform patients about available trials
• C. Financial assistance for trial participation is mandatory
• D. Trials must be conducted within the hospital only

Answer: (B)

CoC standard 4.7 emphasizes the importance of providing patients with information about available clinical trials as a crucial component of cancer care. This standard is grounded in the belief that patients should have access to cutting-edge treatments and be made aware of all their options, including participation in clinical trials that may offer promising therapeutic opportunities not available through standard protocols.

By ensuring that cancer programs actively inform patients about available trials, the standard aims to support patient autonomy and knowledge, allowing individuals to make informed decisions about their treatment pathways. This proactive approach encourages participation in research that can advance cancer treatment and improve overall patient outcomes.

The other options do not align with the intent of standard 4.7. For instance, mandating patient participation in trials regardless of their choice undermines the ethical principle of informed consent. Similarly, making financial assistance mandatory for trial participation or limiting trials to hospital settings does not reflect the broader and more inclusive framework encouraged by the CoC regarding patient engagement in clinical research.